Company Overview & Resources
Sight AI Press Kit
Who are we?
Sight AI is a medical technology company dedicated to promoting & providing high quality medical & health screening services. With the use of AI technology and partnerships with hospitals, clinics, optical stores, we hope to help potential patients detect and identify early chronic diseases or health risks prior to the onset of overt clinical complications.
Through our comprehensive medical and health network, patients could come in for eye health screening, reporting and referral in the same visit; enabling timely treatment and care.
Our retina AI detection technology focuses on screening common eye diseases that cause various chronic and fundus disease complications, irreversible vision impairment and even blindness.
OCBC Centre East, Singapore
We strive to enhance medical diagnosis in health care. We work with experienced, professional medical experts to bring safe, reliable and sophisticated artificial intelligence solutions to every patient.
We believe in high-quality, holistic healthcare services. Our goal is to enhance the health and wellbeing of every patient through our comprehensive AI Health Risk Assessment System. We envision becoming the most trusted healthcare partner.
Meet our executive leadership team - focusing on strategical, technological, operational and financial decision-making management for the entire company.
Chief Technology Officer
Jack Chen Ming Qiang
Leveraging on his extensive experience in medical and healthcare AI, Jack Chen leads the R&D team, spearheading development for all digital, data and technology products to improve the engagement between patients, primary care networks and specialists.
Jack leads the efforts in introducing AI-driven predictive algorithms to conduct preliminary reading for eye diseases to accelerate patient's path to required care and treatments.
Jack earned a bachelor's degree in computer science and technology from Wuhan University and a master's degree from the Graduate School of the Chinese Academy of Sciences. Prior to Sight AI, Jack played an integral role in the Yahoo! Main message push platform during his time in Yahoo's Beijing global R&D Center. He later joined Airdoc as their pioneering team in a technical lead role.
Chief Operation Officer
Providing strategic financial and commercial leadership, Vera leads the company’s corporate finance functions, human resources operations and commercial operations as well as oversees the company’s global compliance and regulatory strategies.
Innovative change agent with over 25 years of experience building complex global operations. 20+ years were in banking and investment research at Goldman Sachs, KKR, and JPMorgan. Expertise in financials controls, general management, and infrastructure with focus on achieving outcomes, and increasing efficiency. Three years of entrepreneurial success building and growing COO consulting services company with effective business collaborations. Experience working in Singapore, Hong Kong, and New York.
She belongs to the Financial Women’s Association (FWA) in Singapore as well as a mentor with the Halogen Foundation Singapore.
Milestones & Achievements
We focus on long-term value creation - with a goal to improve lives through enabling access to easy and effective healthcare services, our timeline captures our commitment to do what is right for our users and end-customers.
June - Dec 2021
Core team assembled in half a year.
Aug - Dec 2021
ISO13485 attain within 3 months of incorporation.
Dec 2021 - Sept 2022
Progressive team expansion, from 6 to 13 headcount.
Jan 2022 - Aug 2022
Forged partnerships with leading eyecare providers.
Mar 2022 - Aug 2022
Joining recruitment drives in Singapore's top educational institutes such as NTU & SMU to actively drive public awareness and recruit top talents.
Attended Asia Pacific MedTech Forum, demonstrating our solution capabilities to medical practitioners, policy makers and hospital groups.
Products & Services
The future of eye care and diagnostic tools is here.
Sight AI Technology Pte Ltd management system has been assessed and certified as meeting the requirements of ISO 13485:2016 and ISO EN 13485:2016 for the design and development, production and distribution of AI software used for fundus images analysis for diagnosis and disease management. Sight AI’s Retina AI Detection System (RAIDS) is currently available for clinical research.
We are undergoing various countries’ regulatory registration (i.e. HSA, MDR & FDA).
Our Product Approach
Instantaneous, easy, effective.
Enable specialists to focus on treatments for early prevention of vision loss
Reduce patient load and allow immediate referral to eyecare specialists
Advanced image processing capabilities
High sensitivity and specificity in the detection of referable diabetic retinopathy.
Creating new revenue streams by providing eye screening as a value-added service
Improved patient experience
Screening, reporting and referrals in one visit
Based on deep learning techniques
Trained with a vast amount of diverse fundus images
AI screening for other eye and non-eye related diseases on the horizon
Compared with conventional, manual eye-screening
Early detection of Diabetic Retinopathy
Logo & Images
Right Click to save images